AptarGroup, Inc. (NYSE: ATR) Q4 2025 earnings call transcript

AptarGroup, Inc. (NYSE:ATR) Q4 2025 Earnings Call Transcript February 6, 2026 Operator: Ladies and gentlemen, thank you for ...

Here’s The Full TrumpRx Discounted Drug List & Who It Actually Helps

The TrumpRx.gov website helps uninsured & cash-paying patients save on 40+ brand drugs. Here's the complete list of ...

Atossa Therapeutics Maintains Strong Market Position for (Z)-Endoxifen for Duchenne Muscular Dystrophy as Congress Reauthorizes Priority Review Voucher Program

Atossa's Rare Pediatric Disease Designation for (Z)-endoxifen in neuromuscular diseases qualifies for a future PRV upon FDA approval SEATTLE, Feb. 5, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc.

TrumpRx delayed as senators question if it’s a giant scam with Big Pharma

The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs ...
ophthalmologytimes

FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain

Urcosimod targets immune-mediated inflammation and dysfunctional nerve signaling, showing potential in treating neuropathic corneal pain. Phase 2 trials demonstrated urcosimod's efficacy in reducing ...
FierceBiotech

Tanabe Pharma's oral drug scores in ph. 3 rare disease study, though details remain in the dark

Tanabe Pharma America’s small molecule designed to boost melanin production has hit the main goal of a phase 3 trial for patients with rare hereditary disorders that cause extreme sensitivity to ...
Reuters

Pharma sector doubles down on AI amid hopes of slashing costs, timelines

Jan 15 (Reuters) - Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools and automated labs to unlock efficiency gains across ...
WDEL-FM

Delaware v. Big Pharma

The Delaware Department of Justice announced on Wednesday, January 14, 2026, that a lawsuit has been filed in the Court of Chancery against the nation's three primary insulin manufacturers, and the ...
Reuters

Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab

SAN FRANCISCO, Jan 12 (Reuters) - Nvidia (NVDA.O), opens new tab and U.S. pharma giant Eli Lilly (LLY.N), opens new tab will spend $1 billion building a new joint research lab in the San Francisco Bay ...
MarketWatch

AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma

AbbVie agreed to acquire a device manufacturing facility in Tempe, Ariz., and the rights to the SmartDose 3.5 milliliter drug-delivery system from West Pharmaceutical Services as part of a deal worth ...